ABSTRACT
INTRODUCTION
Atopic dermatitis (AD), a skin manifestation of atopy, is a common chronic inflammatory disease characterized by impaired epidermal barrier function, cutaneous inflammation and a course of remissions and exacerbations 1,2 . It affects 5-30% of children and 2-10% of adults worldwide, with genetic and environmental factors contributing to the disease 3 . Most of AD patients manifest the disease during infancy and the condition generally improves in severity, but may remit by adolescence or early adulthood The eczematous skin of AD patients is highly susceptible to infection and colonization by various microorganisms, in comparison to healthy children, with Staphylococcus aureus (S. aureus) being the most frequent isolate [5] [6] . Colonization by staphylococci is not restricted to eczematous lesions, but tends to spread to other sites by self-contamination 7 . Studies have shown that 80-100 % of AD patients have nasal or skin colonization by S. aureus, while it is only 5-30% in individuals without AD 8 . Evidence suggests that human antimicrobial peptides, such as defensins and cathelicidins which play roles in inhibiting S. aureus colonization, are decreased in patients with AD, besides; the skin barrier breakdown that occurs in AD facilitates penetration of the skin by the colonizing bacteria 9 . In addition, the cell wall components of S. aureus such as cell-surface adhesins, 2 antiphagocytic factors and secreted exotoxins help skin colonization 10 . Skin colonization by S. aureus as well as the density of the organism on skin lesions is positively correlated to the severity of the disease 6 . S. aureus worsens AD by secreting superantigen toxins e.g. staphylococcal enterotoxins SEA, SEB, SEC, SED and toxic shock syndrome toxin-1 (TSST-1), which contribute to the progression and severity of AD by stimulating T cells to release pro-inflammatory cytokines and by rendering them non-responsive to corticosteroids 11,12 . The antibiotic -corticosteroid combination therapy against S. aureus represents an important part of the therapeutic approach to AD 13 . The use of topical or oral antibiotics can temporarily reduce colonization and improve symptoms. However, the emergence of antibiotic resistance is a serious and a growing problem in treatment of AD
14
. The present study was conducted to assess the colonization of AD pediatric patients with S. aureus and to characterize the superantigen gene profile of the isolates and their effect on AD severity. A further aim of the study was to detect the antimicrobial resistance pattern as well as the presence of multiple drug resistant (MDR) strains in relation to disease severity and superantigen gene presence in Egyptian pediatric AD patients.
METHODOLOGY

Study design and subjects
This case-control study was conducted in the Microbiology & Immunology and the Dermatology departments. The study included two groups; a patients' group of 53 children (28 boys and 25 girls) suffering from AD with their ages ranging from 6 months to 14 years (mean= 5.87 ± 4.1 years). All of them were presented to the outpatient Dermatology Clinic at Zagazig University Hospital (ZUH). AD was diagnosed following the criteria of Hanifin and Rajka 15 . The severity of the disease was assessed using the scoring atopic dermatitis (SCORAD) index 16 . Exclusion criteria included; the presence of any other skin infection (bacterial, fungal or viral) that may obscure the diagnosis, treatment with systemic steroids, immunosuppressive drugs or systemic antimicrobials in the past 4 weeks, and treatment with topical antibiotics in the past 2 weeks. Forty five apparently healthy children (26 boys and 19 girls) served as the second; control group. Their ages ranged from 3 months to 15 years (mean= 6.1 ± 4.25 years). Informed written consents were obtained from parents or guardians of all participants.
Sampling and isolation of S. aureus
Sterile cotton-tipped swabs were used for sampling. Swabs were dipped first in sterile saline and then used to obtain samples from lesional skin of AD patients, as well as their healthy (non-lesional) skin and nares, while samples of the control group were collected only from the nares. All samples were then plated on blood agar and mannitol salt agar (Oxoid Ltd, UK) and incubated for 24-48h at 37˚C. Suspected colonies were further identified as being S. aureus by their morphology (gram positive, cluster forming cocci), positive catalase reaction and positive DNase reaction (Oxoid Ltd, UK). Colonies were then stored at -20˚C in trypticase soy broth (Sigma-Aldrich, USA) with 15% glycerol (vol/vol) till their further use. DNA extraction and Polymerase Chain Reaction (PCR) for superantigen genes DNA was extracted from S. aureus isolates using QIAamp DNA MiniKit (Qiagen, Germany) according to the manufacturer's instructions. Lysozyme (SigmaAldrich, USA) (20 mg/ml) was added for the lysis step. PCR assays were performed on all isolates for the following genes; femA as an internal control gene, mecA for confirmation of methicillin resistance, toxic shock syndrome toxin (tsst-1) gene and staphylococcal enterotoxins A-E genes (sea, seb, sec, sed and see) using previously described primers and protocols 17 . Two multiplex reactions, each targeting four genes, were performed for each isolate. The reactions were performed in 20 µl reaction mixtures using Maxime PCR PreMix Kit (i-Taq) (iNtRON Biotechnology, Korea) ready to go PCR beads. Twenty µM of each primer were added. All primers were supplied from The Midland Certified Reagent Company Inc. (Texas). PCR reactions were carried on using Biometra T gradient (Germany) thermal cycler. PCR products were examined under UV light after electrophoresis using 1.5% agarose gel. Product sizes were identified using a suitable DNA marker (GeneOn, Germany).
Antimicrobial susceptibility testing
The disc diffusion method was used to perform the antimicrobial susceptibility testing according to the Clinical and Laboratory Standards Institute (CLSI, 2012) guidelines 18 . The following antimicrobial discs (Oxoid Basingstoke, UK) were used; penicillin (10 units), cefazoline (30 µg), gentamycin (10µg), erythromycin (15µg), trimethoprim-sulfamethoxazole (TMP-SXZ) (1.25/23.75), clindamycin (2µg), chloramphenicol (30µg), tetracycline (30µg), fusidic acid (10µg) and vancomycin (30µg). In addition, high mupirucin resistance was examined using 200µg mupirucin disc and resistance to methicillin was examined by using a 30µg cefoxitin disc and confirmed by the presence of the mecA gene by PCR. Plates were incubated at 35˚C for 16-18h. Those for cefoxitin were left for 24h.
To determine the inducible macrolide-lincosamide streptogramin B (MLS B ) resistance, the D-zone test was performed according to CLSI guidelines (2012) on all S. aureus isolates that were clindamycin susceptible and erythromycin resistant 18 . Following incubation (18h at 35˚C), organisms that did not show flattening of the clindamycin zone were reported as clindamycin susceptible. Isolates that showed flattening of the clindamycin zone adjacent to the erythromycin disc indicated inducible clindamycin resistance 19, 20 . Isolates that were resistant to three or more antimicrobial classes were considered as multidrug resistant (MDR) isolates 21 . S. aureus ATCC 25923 (Manassas, VA, USA) was used as a control strain in antimicrobial susceptibility tests 18 .
Statistical analysis
Data were checked, entered and analyzed using EPI-INFO 6 for data processing and statistics. Student "t" test and Chi-square test (X 2 ) were used when appropriate. P values <0.05 indicated significant results.
RESULTS
This study included 53 AD patients as well as 45 control subjects whose demographic and clinical data are presented in table 1. Among the included 53 AD patients, 13 (24.5%) had severe AD, 22 (41.5%) had moderate AD, while 18 patients (34%) had mild disease. A number of 47 patients (47/53, 88.7%) were found to be colonized in one or more sites with S. aureus. All the 47 patients had S. aureus colonization on their lesional skin. Colonization on non-lesional skin was found in 66% (35/53) and nasal colonization was present in 39.6% (21/53) of AD patients. Seventeen patients (17/53, 32.1%) were found to be colonized in the three examined sites. On the other hand, only 11 subjects (11/45, 24.4%) of the control group had nasal colonization with S. aureus. The frequency of S. aureus colonization in AD patients was found to be significantly higher (P < 0.0001) than that of the control children (table 1) .
All patients with severe AD (n=13) had S. aureus colonization on their lesional skin, while the ratio was 85% in other patients (34/40) with moderate and mild AD. Furthermore, colonization by S. aureus was found to be significantly associated with the severity of AD where the SCORAD index of colonized patients (mean 23.1 ± 13.4) was significantly higher (P= 0.001) than that of non-colonized patients (mean 12.5 ± 4.7).
Within a total of 159 samples collected from our patients, 103 S. aureus isolates were detected, compared to 11 isolates recovered from the 45 samples of the control subjects (table 1) .
Analysis of the superantigen gene profile of the obtained isolates revealed that thirty one isolates (30.1%) out of those obtained from AD patients (n=103) harbored superantigen genes compared to 3 (27.3%) isolates among those obtained from the control group (n=11). Out of the examined superantigen genes, sea was the only gene detected in the 3 control group isolates. On the other hand, a different superantigen gene profile was obtained from S. aureus isolates of AD patients (table 2) . The most prevalent superantigen gene detected in patients' isolates was sea being found in 20 (64.5%) out of those harboring superantigen genes (n=31), followed by seb (10/31, 32.3%), sec (2/31, 6.5%), then tsst-1 (1/31, 3.2%). Two isolates (2/31, 6.5%) had more than one superantigen gene. One of them had both sea and sec, while the other had both sec and tsst-1. None of the examined isolates was found to carry sed or see genes. Despite the previous findings, the presence of superantigen genes did not differ significantly (P=0.8) between S. aureus isolates of AD patients and those of the control group.
Our data indicated that the frequency of colonization with S. aureus isolates that harbor superantigen genes was significantly higher (P=0.005) in patients with severe disease compared to other patients (table 3) . Furthermore, a significantly higher (P=0.04) SCORAD index (mean 26.7 ± 13.9) was recorded in patients colonized with strains harboring superantigen genes compared to those colonized with strains lacking superantigen genes (mean 18.6 ±11.7).
On studying the antimicrobial resistance pattern of isolates, the resistance to methicillin (MRSA) was detected in 8 (7.8%) out of all S. aureus isolates (n=103) obtained from AD patients. Five of which were isolated from lesional skin samples (5/47, 10.6%), while the other 3 MRSA isolates were obtained from non-lesional skin (2/35, 5.7%), as well as from patients' nares (1/21, 4.8%) isolates. None of the S. aureus isolates obtained from the healthy children (n=11) was found to be resistant to methicillin. However, this difference was statistically insignificant (P=0.3). Similarly, no significant difference was found between S. aureus isolates from AD patients and those from the control group regarding the other tested antimicrobials (table 4) .
Sixty five isolates (63.1%) of those obtained from AD patients (n=103) were MDR, compared to 8 isolates (72.7%) from the control group (n=11). Within the MDR isolates obtained from patients, 30 isolates (30/47, 63.8%) were from lesional skin, 23 isolates (23/35, 65.7%) were from non-lesional skin, while 12 isolates were from the patients' nares (12/21, 57.1%). MDR strains were isolated from one or more of the examined sites of 39 patients (39/47, 83%), 8 of which (8/47, 17%) were found to be colonized with MDR isolates in all the three examined sites (lesional, non-lesional skin and nares).
On comparing the SCORAD index of patients harboring MRSA on their skin and/or nose, no significant difference (P=0.2) was found between them (mean 31 ± 17.3) and those having no MRSA isolates (mean 21.7 ± 12.4). On the other hand, the SCORAD index of AD patients colonized with MDR on their diseased skin (mean 28.3 ± 14) was significantly higher (P = 0.0002) than that of those lacking MDR isolates (15.5 ± 8.1). Moreover, the SCORAD index of AD patients colonized with MDR in the 3 examined sites (mean 37.1 ± 11.6) was also significantly higher (P = 4 0.005) than those colonized in one or two sites only (mean 16 ± 12.4).
The relation between the presence of superantigen genes and antimicrobial resistance is demonstrated in table 5, which shows the distribution of superantigen genes in MRSA as well as MDR isolates. Within the MRSA isolates obtained from AD patients (n=8), seb was the most prevalent gene being detected in 37.5% of isolates, while sea was the most prevalent superantigen gene in methicillin susceptible S. aureus (MSSA) (20%), MDR (23.1%), as well as non MDR isolates (13.2%). (0) - (0) 1 (5.5) 8 (80) 2 (20) - (0) - (0) - (0) - (0) 3 (100) - (0) - (0) - (0) - (0) -(0) *One isolate had sec in addition to sea and another isolate had sec in addition to tsst- 
DISCUSSION
Despite that both genetic and environmental factors contribute to the susceptibility and severity of AD, evidence suggests that S. aureus may play a key role in the pathogenesis of the disease 3, 10 . S. aureus can produce cell-surface adhesins, antiphagocytic factors and superantigen exotoxins, defined by their ability to stimulate massive cytokine release from both T cells and macrophages, this in turn may account for the severe manifestations of the disease
11,12
. Multiple factors make the skin of AD patients vulnerable to S. aureus colonizazion, this include the altered epidermal barrier function, increased bacterial adhesion by the underlying skin inflammation and decreased innate immune responses
9, 10
. In this study, colonization of Egyptian AD pediatric patients with superantigen producing S. aureus strains is described in relation to the severity of the disease and the antimicrobial resistance pattern of the isolates.
We found 88.7% of our pediatric AD patients to be colonized with S. aureus on their lesional skin areas, 66% were colonized on their non-lesional skin and 39.6% had nasal colonization, compared to 24.4% colonized subjects of the control group. This difference showed a statistical significance (P<0.0001). These findings are consistent with data published by other researchers 22 , even higher ratios reaching a 100% colonization rate was reported by Guzik and his colleagues 6 . Meanwhile, other studies found lower rates of colonization (42.2% -65%)
23-24
. A possible explanation of this variation between studies might be that the majority of cases are colonized only intermittently, therefore S. aureus is not always detected at time of examination 25 . Moreover, different sampling techniques and the hygienic status of patients may also contribute to this variation 23 . We detected that all the severe cases in our study and 85% of the moderate and mild cases were colonized with S. aureus, which was in agreement with the results obtained by Alenizi and Gomes et al.
24,26
, while David and Cambridge reported the isolation of S. aureus only in 53% of severe AD and in 100% of their moderate and mild cases 27 . On assessment of AD severity of our patients using the SCORAD index, we found a significant difference (P=0.001) between the score of children colonized with S. aureus (mean=23.1±13.4) and those who were not 6 colonized (mean=12.5±4.7). This result agrees with other reports 22 and confirms the role of S. aureus colonization in worsening AD eczema 11, 12 . In the current study, analysis of the superantigen toxin gene profile of the isolates revealed that 30.1% of the isolated S. aureus strains harbored one or more of the superantigen toxin genes. This result comes in accordance with previous studies which showed that 30-60% of strains isolated from AD patients secrete exotoxins with superantigenic properties
12, 28
. While, Silva and his coworkers stated that all strains of S. aureus (100%) isolated from AD patients in their study were toxigenic 29 . In most of our cases, one superantigen gene was detected and only two cases showed the presence of 2 toxin genes in the same isolate. The sea gene was the most frequently detected gene in 64.5% of cases, followed by seb (32.3%), sec (6.5%) and tsst-1(3.2%). While, sea was the only gene found in the 3 isolates bearing superantigen genes from the control group. Our findings differed from those of Nada et al., who found seb to be the most prevalent gene in their isolates
22
. This confirms the diversity in the proportion and frequency of toxin producing S. aureus isolates between studies 5, 12, 30 . Clinical data provide further evidence supporting the role of superantigens in the pathogenesis of AD, as the application of the prototypic superantigen, staphylococcal enterotoxin B, to unaffected atopic or healthy skin induces eczematous skin changes of erythema, induration, and mononuclear cell infiltration
31
. In addition, it was observed that treatment of AD with a combination of corticosteroids and antibacterial agents is often more effective than corticosteroid therapy alone 32 . Our data indicated that a significantly higher frequency of colonization (P=0.005) with S. aureus isolates that harbor superantigen genes was found in severe AD patients compared to other patients. Furthermore, a significantly higher (P=0.04) SCORAD index was detected in patients colonized with superantigen producing strains compared to those colonized with strains lacking superantigen genes. This is consistent with the studies of Nada et al. who demonstrated the participation of S. aureus superantigen toxin activity in the enhancement of AD severity as quantified by SCORAD index 22 . Regarding the antimicrobial resistance pattern, we tested our S. aureus isolates against a battery of the commonly used antimicrobials with the organism. In our study, MRSA accounted for 7.8% of the colonizing S. aureus isolates. This colonization rate is consistent with the results of Lee 23 . No MRSA was detected within the control group isolates in our study.
Our study results revealed that AD patients are a source of resistant S. aureus strains, we found 63.1% of isolates from AD children to be MDR strains, with 88.3% of the isolates resistant to cefazoline, 85.4% to penicillin, 51.4% to erythromycin and 45.6% to gentamycin, but no vancomycin resistance was detected. Similarly, Hoeger, and Alenizi isolated strains of S. aureus that are resistant to many of the commonly used antibiotics
14, 24
. On comparing the SCORAD index of patients colonized with MDR strains to those colonized with non MDR ones, we found a statistical significant difference between them (P=0.0002). Moreover, the SCORAD index of patients colonized with the MDR strains in all of the 3 examined sites was significantly different from those colonized with MDR strains in only 1 or 2 sites (P=0.005), which highlights the contribution of virulent S. aureus in aggravating AD.
In an attempt to find the relation between different virulence factors carried by S. aureus isolates from our patients, we assessed the distribution of the superantigen genes among our antibiotic resistant isolates. The seb toxin gene was detected in 37.5% of MRSA isolates, followed by sea (12.5%). Within MDR strains, sea was the most frequently found gene, followed by seb, sec and tsst-1(23.1%, 10.8%, 3.1% and 1.5%, respectively). The sec and tsst-1 genes were found in MSSA and MDR isolates but not in MRSA isolates. Sila and his colleagues also detected sea, seb and sed, frequently in MRSA, while sec and tsst-1 were more frequent in MSSA
35
. The current study clearly emphasizes that S. aureus strains colonizing AD patients harbored and expressed molecules associated with virulence, as superantigen toxin genes and antimicrobial resistance. These factors are associated with disease severity and can have a strong impact on the clinical outcome. More attention should be paid for performing antibiotic susceptibility testing and monitoring bacterial resistance before initiating treatment, to decrease the risk of dissemination of MDR strains and for better management of AD.
